DOI · e01.org

The C-reactive Protein/Albumin Ratio Is an independent Prognostic Factor for Overall Survival in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy

Changjuan Tao, Yuanyuan Chen, Feng Jiang, Xinglai Feng, Qifeng Jin, Ting Jin, Yongfeng Piao, Xiaozhong Chen · Journal of Cancer · 2016

  • DOI 10.7150/jca.16210
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2016

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2016

Abstract

This study aims to investigate the prognostic value of the C-reactive protein/albumin (CRP/ALB) ratio in nasopharyngeal carcinoma (NPC) in the intensity-modulated radiotherapy (IMRT) era.A total of 719 patients with NPC treated between January 2007 and December 2012 were retrospectively reviewed.Serum albumin and CRP levels were measured before treatment.The associations between the CRP/ALB ratio and clinicopathological parameters were analyzed.Multivariate analyses using the Cox proportional hazards model were performed to identify significant prognostic factors associated with overall survival (OS).The prognostic value of the CRP/ALB ratio was determined using receiver operating characteristic (ROC) curve analysis.The optimal CRP/ALB ratio cutoff value was 0.141.High CRP/ALB ratio was significantly associated with older age (P < 0.001), more advanced T category (P < 0.001) and advanced TNM stage (P = 0.024).Patients with an elevated CRP/ALB ratio (≥ 0.141) had poorer OS than those with a CRP/ALB ratio < 0.141 (5-year OS rates: 91.9% vs.

78.1%;P < 0.001).Multivariate analysis suggested clinical T category [hazard ratio (HR) 2.284; 95% confidence interval (CI), 1.429-3.652;P = 0.001]; clinical N category (HR 1.575; 95% CI, 1.007-2.464;P = 0.047) and CRP/ALB ratio (HR 2.173; 95% CI, 1.128-3.059;P = 0.015) were independently associated with OS.In conclusion, pretreatment CRP/ALB ratio is an objective biomarker with significant prognostic value for OS in NPC.The CRP/ALB ratio can enhance conventional TNM staging to stratify patients and may help facilitate individualized treatment of high-risk cases.

Open the resolved locator · 10.7150/jca.16210

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:07 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v07p2005.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.